Status: Recruiting
A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH
This Phase 1 trial will explore the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and multiple ascending doses of INI-822 in healthy volunteers in Parts A, B, and D and in participants with a history of NASH or presumed NASH in Part C.
Participants needed: 104
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Inipharm Australia Pty LtdUpdated: Feb 5, 2025Locations: 7
Eligibility criteria
Females must not be pregnant or lactating, and must use acceptable, highly effec... [+13]
An underlying physical or psychological medical condition that, in the opinion o... [+38]